Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironment
US10919950B2 · kind B2 · utility
1Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2017 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Mar 22, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16043
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present application relates to fusion proteins, chimeric antigen bearing cells expressing fusion proteins and compositions comprising chimeric antigen bearing cells expressing fusion proteins. The application further relates to methods of using the fusion proteins, cells and compositions for modulating an immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.